Bioniche Life Sciences Inc (Belleville, Ontario) has introduced Sotradecol Injection to the US market. The product is approved by the FDA for the treatment of small, uncomplicated varicose veins of the lower extremities. Sotradecol Injection is used in sclerotherapy (nonsurgical vein removal). An estimated 1.7 million individuals undergo sclerotherapy each year in the United States. Sotradecol Injection is available in 2 strengths, 1% and 3%, and is packaged in 2-mL vials. For more information, visit www.bioniche.com, or call 888-258-4199.
Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota.
Clinical features with downloadable PDFs